Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

The purpose of this study is to assess the prevalence of mycoplasma hominis, ureaplasma urealyticum, neisseria gonorrhea, and chlamydia trachomatis in women with overactive bladder symptoms, and to correlate these findings with cystoscopic and urodynamic findings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Overactive Bladder Syndrome

Age range

16 year and older

Sex eligibility

Female

Study type

Observational

Primary location

University Hospital Zurich, Gynecology

Zurich, Canton of Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

women with urogynecologic and urodynamic examination at our institution between 1.1.2009 and 31.12.2011

Exclusion criteria

none

Treatment and study plan

retrospective data analysis

Procedure

retrospective data analysis

Primary outcomes

prevalence of ureaplasma urealyticum

Time frame: time of urogynecologic assessment
prevalence of mycoplasma hominis

Time frame: time of urogynecologic assessment
prevalence of neisseria gonorrhea

Time frame: time of urogynecologic assessment
prevalence of chlamydia trachomatis

Time frame: time of urogynecologic assessment

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2013
First posted: Mar 21, 2012
Registry last updated: Dec 16, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed